<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

2 min read

Continued Growth: Q222 Advanced Wound Care Market Recap

9/22/22 9:30 AM

Q222 AWC Market Header v2WW Advanced Wound Care continues to grow in the mid-single-digits as company revenues reflect normalcy in wound care with a likely increase in wound severity.

For Q222, SmartTRAK Financial Dashboard reports the WW Advanced Wound Care (AWC) market grew +6.4%. WW Advanced Dressings and WW Wound Biologics were also up, while NPWT-heavy External Devices revenue increased marginally.

Among the many topics covered in detail in our comprehensive Q222 Advanced Wound Care Market Recap* are:

  • Complete Q222 AWC Overview and Highlights
  • SmartTRAK's Expert Analysis and Insights
  • All Company News including Revenues, Data, Charts and Shares
  • Growth Analysis – Currency Having a Significant Impact in Q2
  • Advanced Dressings Market Having Another Solid Quarter
  • Biologics Growth Remains Strong with Sustained Double-Digit Gains
  • NPWT Tilts Positive with Currency Movements Clouding Performance
3M* remains the global revenue leader in WW AWC with Smith+Nephew* (SNN) holding onto the second-place position despite a Q2 that was negatively impacted by currency movements. Mölnlycke* rounds out the top three WW AWC companies, driven by ...


Read the entire Q222 Advanced Wound Care Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*The entire unedited article and these links can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.Learn More about Subscribing to SmartTRAK


SmartTRAK is a comprehensive, easy-to-use, business intelligence solution for the Life Sciences Industry that provides breaking updates on pertinent company news, potential treatments and guidance, international survey results, statistical analysis by country, studies, trial results, financial impact and more. All subscribers receive a Daily Updates email containing the latest need-to-know news curated by our expert analysts. It's the perfect way to start your day! If you would like to learn more about SmartTRAK, just click here.
Gary Delhougne
Written by Gary Delhougne

SmartTRAK GM, Wound. Licensed attorney with 20 years’ medical device and consulting experience in market access, health economics and policy roles at Smith & Nephew, Covidien, Avalere Health and Ernst & Young.

  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles